Ignite Creation Date:
2025-12-24 @ 6:32 PM
Ignite Modification Date:
2026-01-05 @ 5:12 PM
Study NCT ID:
NCT01614457
Status:
COMPLETED
Last Update Posted:
2015-02-12
First Post:
2012-06-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have the R117H-CF Transmembrane Conductance Regulator (CFTR) Mutation (KONDUCT)
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cystic Fibrosis | View |
Keywords: